Fw: Make Embryonic Stem Cell Research Legislation a Priority this Fall

[Guest guest]

I thought this may be of some interest to our group:

a ( Bobby ) Doyle, dob 12/17/29

DX 5/1995

Interferon 9 weeks/Hydroxyurea 5 years

02/2000 to 06/2002 Gleevec trial, OHSU

06/2002 Gleevec/Trisenox Trial, OHSU

06/2003 Gleevec/Zarnestra Trial, OHSU

04/2004 Sprycel Trial, MDACC, CCR in 10 months

04/2008 XL228 Trial, U of Mich.

01/2009 PCR 5.69

04/2009 Ariad Trial AP24534

09/2009 PCR 0.01

11/2009 PCR 0.034

02/2010 PCRU

#840 Zavie's Zero Club

From: Parkinson's Action Network <rcd1929@...>

Subject: Make Embryonic Stem Cell Research Legislation a Priority this Fall

" Parkinson's Action Network " <rcd1929@...>

Date: Wednesday, October 20, 2010, 3:09 PM

Thank you for using Parkinson's Action Network Mail System.

Message sent to the following recipients:

Representative Sutton

Senator Brown

Senator Voinovich

Message text follows:

a Doyle

6895 Mill Rd

Brecksville, OH 44141-1809

October 20, 2010

[recipient address was inserted here]

Dear [recipient name was inserted here],

As a member of the Parkinson's community, I am looking to you to ensure

that federal funding is restored for human embryonic stem cell (hESC)

research.  Please support the passage of the Stem Cell Research

Advancement Act of 2009 (H.R. 4808) and the Stem Cell Research Advancement

Act of 2010 (S. 3766).

It is imperative to restore federal funding for this promising research. 

hESC research holds the potential of delivering better treatments and

possibly cures for diseases like Parkinson's.  Researchers should not have

to terminate research projects midstream, invalidate results in process,

and impede or negate years of scientific progress.

Parkinson's disease is a chronic, progressive neurological disease.

Currently there is no cure, therapy, or drug to slow or halt the

progression of Parkinson's disease.  While medication masks some symptoms

for a limited period, generally four to eight years, dose-limiting

side-effects do occur after time.  Eventually the medications lose their

effectiveness, leaving the person unable to move, speak or swallow.

Are you going to make stem cell research legislation a priority this fall

so that this potential life-saving research can continue?  I hope that you

will join with the majority of Americans who support this promising

research and pass H.R 4808 and S. 3766.

I look forwarding to hearing from you regarding your support for hESC

research.

Sincerely,

a Doyle

440-526-0124